Diagnosis

  • Ark Surgical secures further institutional backing to accelerate US expansion

    Women’s health medical device company Ark Surgical has secured further institutional backing from JNF and the Israel Innovation Authority (IIA) as it accelerates the US commercial expansion of its surgical tissue containment technology. Both organisations have previously backed Ark, making the renewed support a significant vote of confidence in the company’s technology, leadership team and [...]

  • Jersey PMOS clinic a ‘good start’

    Jersey is launching a pilot PMOS health check clinic for women to improve follow-up care and access to specialist support. The clinic will operate at the Assisted Reproductive Unit in St Brelade from October, providing health checks rather than diagnosing or treating the condition. Women with polyendocrine metabolic ovarian syndrome (PMOS) will need to see [...]

  • Major UK study could be a ‘game-changer’ for heavy periods and endometriosis

    A UK study will build a menstrual fluid biobank to help women get faster, better treatment for heavy periods. Thousands of participants will provide menstrual fluid samples over three cycles using specially designed period pads. They will also use a daily tracking app and complete detailed questionnaires. Researchers from the Universities of Exeter and Bristol [...]

  • Millions in England to be offered ‘gamechanging’ home testing kits for cervical cancer

    Millions of women who have missed cervical screening in England will be offered free NHS home HPV tests. The initiative is aimed at women who are not up to date with screening, with NHS estimates suggesting as many as 4 million have fallen behind. The home kits contain a swab for collecting a vaginal sample, [...]

  • Study to tackle years-long delays in endometriosis diagnosis

    A study is examining where delays occur in diagnosing endometriosis  - a condition that can take seven to twelve years to diagnose. Endometriosis affects an estimated 1.5 million women and people in the UK, but there is currently no consistent way of measuring where and why diagnostic delays happen. The research aims to develop the [...]

  • Calla Lily joins US$50m antibiotics programme

    Calla Lily Clinical Care has joined a US$50m antibiotics programme to assess vaginal delivery of UTI treatments through its Callavid platform. The women’s health medical technology company will evaluate whether antibiotics can be delivered directly through the vaginal wall to treat urinary tract infections (UTIs). The project will use Callavid, the company’s intravaginal drug delivery [...]

  • Adverse pregnancy outcomes linked to greater social needs in Black and Latina women – study

    Pregnancy complications are linked to greater health-related social needs among Black and Latina women, a study has found. Adverse pregnancy outcomes include pre-eclampsia, gestational hypertension, gestational diabetes, low birth weight and preterm birth. These complications are associated with risks of further complications, chronic disease and cardiovascular disease, and disproportionately affect Black and Latina women. [...]

  • Chemicals in plastics may be linked to high blood pressure during pregnancy

    Phthalates found in plastics and personal care products may be linked to higher blood pressure during pregnancy, a study suggests. Hypertensive disorders of pregnancy, including pre-eclampsia, are a leading cause of maternal mortality in the US. Higher blood pressure during pregnancy has also been linked to adverse health outcomes for both mothers and children. [...]

  • Glaucoma drugs could one day be used to treat breast cancer – study

    Glaucoma drugs could potentially be repurposed to treat aggressive breast cancer after researchers identified markers linked to response. Scientists found that several cancers, including breast cancer, melanoma and a type of blood cancer, rely on the same molecule to become aggressive and spread. Drugs that block the molecule are already used to treat glaucoma and [...]

  • Where women live may influence ovarian cancer survival, especially among Black women – study

    Women living in socially vulnerable neighbourhoods had a 20 per cent higher risk of death after an ovarian cancer diagnosis, a study found. Black women also faced a 45 per cent higher risk of death than white women. Researchers said the combination of being Black and living in a highly vulnerable neighbourhood was linked to [...]